Local oestrogen for vaginal atrophy in postmenopausal women (Q24247740)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Local oestrogen for vaginal atrophy in postmenopausal women (English)

0 references

1 reference

J Suckling

1

0 references

A Lethaby

series ordinal

2

0 references

R Kennedy

series ordinal

3

0 references

publication date

20 October 2003

0 references

published in

0 references

cites work

Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Clinical trial of the estradiol vaginal ring in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Vaginal administration of low-dose oestradiol--effects on the endometrium and vaginal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Prevalence of genito-urinary symptoms in the late menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Urogenital aging: solutions in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Review of the endometrial safety during intravaginal treatment with estriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Clarifying the Ethics of Clinical Research: A Path toward Avoiding the Therapeutic Misconception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Climacteric symptoms among women aged 60-62 in Linköping, Sweden, in 1986

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Effects and acceptability of a new 17 beta-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaints

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Vaginal pH as a marker for bacterial pathogens and menopausal status

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Comparative study: Replens versus local estrogen in menopausal women.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

Estriol: absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001500

7 January 2021

10.1002/14651858.CD001500

Identifiers

DOI

0 references

Fatcat ID

release_4bawlpazdrbc7oqvmrov7hrqty

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4bawlpazdrbc7oqvmrov7hrqty

24 November 2022